Navigation Links
CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
Date:4/1/2008

CHICAGO, April 1, 2008 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) today announced new data presented at the 57th Annual Scientific Sessions of the American College of Cardiology shows that Ranexa(R) (ranolazine extended release tablets) significantly reduced the risk of recurrent ischemia (p=0.002), worsening angina (p=0.048) and intensification of antianginal therapy (p=0.009) in angina patients (n=3,565) in the MERLIN- TIMI 36 study.

Additionally, Ranexa significantly improved all measures of exercise performance compared to placebo, including reductions in the time to onset of angina (p=0.002) and time to the onset of 1 mm ST segment depression (p=0.002), a signal of ischemia, in these MERLIN-TIMI 36 angina patients.

"MERLIN-TIMI 36 is the largest study of ranolazine in patients with established coronary artery disease," said David Morrow, M.D., MPH, of Brigham & Women's Hospital at Harvard Medical School and lead investigator of the MERLIN-TIMI 36 study. "This new subgroup analysis shows consistent safety and efficacy across a broader group of angina patients than those studied previously and reaffirms ranolazine as an option for treating chronic angina."

Study Design

MERLIN-TIMI 36 (Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes) was a multi-national, double-blind, randomized, placebo-controlled, parallel-group clinical trial designed to evaluate the efficacy and safety of Ranexa during acute and long-term treatment in 6,560 patients (3,279 received ranolazine, 3,281 received placebo) with non-ST elevation ACS treated with standard therapy.

Previously published data from the MERLIN-TIMI 36 study has shown that Ranexa was safe i
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
2. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
3. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
4. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
5. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
6. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
7. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
10. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
11. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading ... H. Burbank , Chief Executive Officer, will present at the ... on Wednesday, March 11 th at 3:50 ... be made available at http://ir.nxstage.com  at the time ... NxStage Medical, Inc. (Nasdaq: NXTM ) is a ...
(Date:3/4/2015)... WASHINGTON , March 4, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
(Date:3/4/2015)...   Aratana Therapeutics, Inc . (NASDAQ: ... licensing, development and commercialization of innovative biopharmaceutical products for ... the Barclays Global Healthcare Conference to be ... Hotel in Miami , FL.  ... and Chief Executive Officer of Aratana Therapeutics, will provide ...
Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2
... Corporation, a Nevada corporation ("MusclePharm" or the "Company") (OTCBB: ... to announce MusclePharm,s preliminary financial results for the third ... preliminary basis, the Company expects unaudited gross revenues for ... $5,700,000, an increase of 305% as compared to gross ...
... PRUSSIA, Pa., Oct. 10, 2011 Medical Alarm Concepts ... first fully-monitored medical alarm system that allows the user ... announced that it has officially launched its new television ... (HM3) one of the leading producers of infomercials and ...
Cached Medicine Technology:MusclePharm Announces Preliminary Third Quarter 2011 Results 2MusclePharm Announces Preliminary Third Quarter 2011 Results 3Medical Alarm Concepts Accelerates Return of MediPendant™ to Airwaves - Well Financed Nationwide Campaign Moving Ahead 2Medical Alarm Concepts Accelerates Return of MediPendant™ to Airwaves - Well Financed Nationwide Campaign Moving Ahead 3Medical Alarm Concepts Accelerates Return of MediPendant™ to Airwaves - Well Financed Nationwide Campaign Moving Ahead 4
(Date:3/5/2015)... Hinton, W.Va. (PRWEB) March 05, 2015 ... looming, but rather here—and it’s a crisis that is ... , In order to stay on top of ... are partnering with PracticeLink to meet face-to-face with physicians ... Career Advancement Workshop and Job Fair series. , Physician ...
(Date:3/4/2015)... March 05, 2015 Understanding China’s New ... 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/UnderstandingChinaMDRegs ... revamped regulations for medical devices in China. , ... devices — research and development, approval, manufacturing, distribution, and ... those currently in development as well as those that ...
(Date:3/4/2015)... 04, 2015 Imagine No Malaria’s 2014 World ... Care2 Innovator Award , an honor given to nonprofit causes ... the Nonprofit Technology Conference (NTC15) in Austin, Texas. ... Methodist Church in Austin, was on hand for the presentation; ... No Malaria. , Imagine No Malaria was one of five ...
(Date:3/4/2015)... The Asia-Pacific phthalic anhydride market is ... by 2019, at a CAGR of 5.9% during ... Browse through the TOC of Asia-Pacific Phthalic Anhydride ... segments, with the help of various tables and ... is a derivative of phthalic acid, which is ...
(Date:3/4/2015)... March 04, 2015 When people talk about ... top artists spread across numerous genres, the Houston Rodeo ... conversation. Each night during the annual livestock show and rodeo, ... to the other activities being held at the event. The ... of performers that will try and get the festival its ...
Breaking Medicine News(10 mins):Health News:Physician Shortage Crisis Worsening 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 3Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3
... ... ... , ... ...
... , ... ... , , , , ... ...
... ... ... , ... , , ...
... bone-building drugs used to prevent and treat osteoporosis may be at ... researchers published today in the British Journal of Cancer. , ... Fosamax, Boniva and Zomita, for more than two years had a ... did not, according to lead author Polly Newcomb, Ph.D., M.P.H., head ...
... who used them lost weight, lowered heart disease risk, ... Workplace wellness programs help employees lose weight and reduce ... , U.S. researchers followed 757 hospital workers who took ... focused on diet and exercise. Data on the participants, ...
... ... ... , ... , , , ...
Cached Medicine News:Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 2Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 3Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 4Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 5Health News:KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs 2Health News:KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs 3Health News:KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs 4Health News:Philadelphia Phillies Host Tug McGraw Foundation to Raise Awareness for Brain Tumors 2Health News:Philadelphia Phillies Host Tug McGraw Foundation to Raise Awareness for Brain Tumors 3Health News:Common osteoporosis drugs are associated with a decrease in risk of breast cancer 2Health News:Workplace Wellness Programs Work 2Health News:Star of TV's The Doctors Helping Put Smiles on Faces of Needy Children in India 2Health News:Star of TV's The Doctors Helping Put Smiles on Faces of Needy Children in India 3
... description: For loading gel sample slots 0.4 ... tips). Uses disposable, flexible, autoclavable, precision tapered ... plunger does not contact sample. Includes ... O-rings, and one plastic spacer. ...
... Analyzer reduces the time, cost, and complexity ... sensitivity and advanced polymers enable you to ... Multiple automation features decrease costly human errors. ... compromising your results. , Perform a wide ...
The Pipetman Large-Volume Kit includes two large-volume pipettes conveniently packaged with filters and tips at an exceptional price....
... this unique offer, you can ... application. Pipetman P2 and P10 ... reagents, and P100 is perfect ... Filter Tips, which are especially ...
Medicine Products: